Placabo
Sponsors
Allergopharma GmbH & Co. KG, Korea Arlico Pharm. Co., Ltd, Oman Medical Speciality Board, Liverpool John Moores University, Cedars-Sinai Medical Center
Conditions
Acute BronchitisAllergic AsthmaAnalgesia AssessmentCaffeineDeep Brain StimulationErectile DysfunctionMetabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)Morbid Obesity
Early Phase 1
Phase 2
To Evaluate the Efficacy and Safety of ALC-2203 in Patients With Acute Bronchitis
CompletedNCT07061925
Start: 2025-04-23End: 2025-11-26Updated: 2025-12-24
SAMe for Prevention of Liver Cancer in MASLD-Related Cirrhosis
Not yet recruitingNCT07495995
Start: 2026-04-15End: 2031-12-31Target: 94Updated: 2026-03-31
Lemborexant on Perioperative Sleep Quality in Patients With Parkinson's Disease Undergoing Deep Brain Stimulation
Not yet recruitingNCT07903038
Start: 2026-11-01End: 2027-12-31Target: 128Updated: 2026-10-29
Phase 3
Phase 4
Effect of Zinc Oxide Ointment on Recurrent Aphthous Stomatitis
CompletedNCT07565181
Start: 2025-06-30End: 2026-03-30Updated: 2026-05-04
Efficacy of Transcutaneous Electrical Neural Stimulation and Tadalafil in Men With Erectile Dysfunction: A Randomized, Double-Blind, Bi-centric, Placebo- and Sham-Controlled Trial
CompletedNCT07574268
Start: 2025-05-01End: 2026-04-01Updated: 2026-09-02
Semaglutide 2.4 mg Once Weekly for Recurrent Weight Gain After Metabolic and Bariatric Surgery (RESURGE)
Not yet recruitingNCT07859150
Start: 2026-10-01End: 2029-04-01Target: 104Updated: 2026-10-05